White House Pushing Big Pharma to Report Payments to MDs
The Obama administration is laying the legal groundwork to strongly encourage (read: enforce) more transparency between pharmaceutical companies and doctors by requiring drugmakers to divulge the details of their monetary exchanges with M.D.s for various services and perks.
The Obama administration is laying the legal groundwork to strongly encourage (read: enforce) more transparency between pharmaceutical companies and doctors by requiring drugmakers to divulge the details of their monetary exchanges with M.D.s for various services and perks. –KA
In these critical times, your support is crucial...The New York Times:
To head off medical conflicts of interest, the Obama administration is poised to require drug companies to disclose the payments they make to doctors for research, consulting, speaking, travel and entertainment.
Many researchers have found evidence that such payments can influence doctors’ treatment decisions and contribute to higher costs by encouraging the use of more expensive drugs and medical devices.
Consumer advocates and members of Congress say patients may benefit from the new standards, being issued by the government under the new health care law. Federal officials said the disclosures increased the likelihood that doctors would make decisions in the best interests of patients, without regard to the doctors’ financial interests.
As we navigate an uncertain 2025, with a new administration questioning press freedoms, the risks are clear: our ability to report freely is under threat.
Your tax-deductible donation enables us to dig deeper, delivering fearless investigative reporting and analysis that exposes the reality behind the headlines — without compromise.
Now is the time to take action. Stand with our courageous journalists. Donate today to protect a free press, uphold democracy and uncover the stories that need to be told.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.